Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial

NCT04382625 is registered in ClinicalTrials.gov with Kootenai Health as lead sponsor.

NCT NCT04382625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04382625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial
Lead sponsor
Kootenai Health
Phase
Phase 4
Overall status
Withdrawn
Start date
October 31, 2020
Completion date
June 1, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov-2 pneumonia